Correlation Between Arbutus Biopharma and ARCA Biopharma

Can any of the company-specific risk be diversified away by investing in both Arbutus Biopharma and ARCA Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arbutus Biopharma and ARCA Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arbutus Biopharma Corp and ARCA Biopharma, you can compare the effects of market volatilities on Arbutus Biopharma and ARCA Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arbutus Biopharma with a short position of ARCA Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arbutus Biopharma and ARCA Biopharma.

Diversification Opportunities for Arbutus Biopharma and ARCA Biopharma

0.59

Correlation Coefficient

Arbutus Biopharma  ARCA Biopharma

Very weak diversification

The 3 months correlation between Arbutus and ARCA is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Arbutus Biopharma Corp and ARCA Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ARCA Biopharma and Arbutus Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arbutus Biopharma Corp are associated (or correlated) with ARCA Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ARCA Biopharma has no effect on the direction of Arbutus Biopharma i.e., Arbutus Biopharma and ARCA Biopharma go up and down completely randomly.

Pair Corralation between Arbutus Biopharma and ARCA Biopharma

Given the investment horizon of 90 days Arbutus Biopharma is expected to generate 8.33 times less return on investment than ARCA Biopharma. But when comparing it to its historical volatility, Arbutus Biopharma Corp is 4.66 times less risky than ARCA Biopharma. It trades about 0.12 of its potential returns per unit of risk. ARCA Biopharma is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  174.00  in ARCA Biopharma on January 19, 2024 and sell it today you would earn a total of  147.00  from holding ARCA Biopharma or generate 84.48% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Arbutus Biopharma Corp  vs.  ARCA Biopharma

Arbutus Biopharma Corp

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Arbutus Biopharma Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Arbutus Biopharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

ARCA Biopharma

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in ARCA Biopharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting forward indicators, ARCA Biopharma displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Arbutus Biopharma and ARCA Biopharma

The main advantage of trading using opposite Arbutus Biopharma and ARCA Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arbutus Biopharma position performs unexpectedly, ARCA Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ARCA Biopharma will offset losses from the drop in ARCA Biopharma's long position.

The idea behind Arbutus Biopharma Corp and ARCA Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.